Chemical Structure : LDN193189
CAS No.: 1062368-24-4
Catalog No.: PC-42884Not For Human Use, Lab Use Only.
LDN193189 (DM 3189) is a potent, selective BMP type I receptor that inhibits BMP4-induced phosphorylation of SMAD1/5/8 with IC50 of 5 nM, displays >200-fold selectivity for BMP signaling over TGF-β signaling (IC50>1,000 nM).
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $128 | In stock | |
25 mg | $198 | In stock | |
50 mg | $328 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LDN193189 (DM 3189) is a potent, selective BMP type I receptor that inhibits BMP4-induced phosphorylation of SMAD1/5/8 with IC50 of 5 nM, displays >200-fold selectivity for BMP signaling over TGF-β signaling (IC50>1,000 nM).
LDN193189 efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 (IC50=5 nM and 30 nM, respectively), with weaker effects on activin and the TGF-β type I receptors ALK4, ALK5 and ALK7.
LDN193189 also blocks the transcriptional activity induced by either constitutively active ALK2 R206H or ALK2 Q207D mutant proteins.
LDN193189 affects BMP-induced osteoblast differentiation, attenuates ectopic ossification in vivo.
M.Wt | 406.4824 | |
Formula | C25H22N6 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
Ethanol: 0.25 mg/mL (Need ultrasonic and warming); DMSO: < 0.1 mg/mL; H2O: < 0.1 mg/mL |
|
Chemical Name/SMILES |
Quinoline, 4-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]- |
1. Yu PB, et al. Nat Med. 2008 Dec;14(12):1363-9.
2. Cuny GD, et al. Bioorg Med Chem Lett. 2008 Aug 1;18(15):4388-92.
3. Cannon JE, et al. Br J Pharmacol. 2010 Sep;161(1):140-9.
4. Steinbicker AU, et al. Blood. 2011 May 5;117(18):4915-23.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright